Stay updated on Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.3.3 was added to the record history. The 'HHS Vulnerability Disclosure' link and the prior 'Revision: v3.3.2' entry were removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:28:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    A new revision v3.3.2 was added and an older revision v3.2.0 was removed from the Record History.
    Difference
    0.1%
    Check dated 2025-11-24T21:16:49.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A government funding status notice was removed from the page. This notice pertained to operating status and does not affect the study's data, recruitment, or results.
    Difference
    0.8%
    Check dated 2025-11-17T18:35:53.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A new version (2019-12-17) was added to the record history with updates to Recruitment Status and Study Status. The version includes a Last Update timestamp.
    Difference
    0.1%
    Check dated 2025-11-03T13:18:25.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a government-operating-status notice and a version upgrade to v3.2.0; removed the previous v3.1.0 marker.
    Difference
    13%
    Check dated 2025-10-06T04:13:44.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.3%
    Check dated 2025-09-28T23:37:29.000Z thumbnail image

Stay in the know with updates to Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety of Sintilimab IBI310 in EBV Gastric Cancer Clinical Trial page.